Quantbot Technologies Portfolio holdings
Quantbot Technologies runs computer-driven trading strategies, buying and selling stocks long and short and holding positions from a few seconds to a few days. The firm was founded in 2009 and also trades options, swaps and futures. It is hired to manage money for private funds, whose investors are institutional investors, high net worth individuals and employees. Paul White is its president and chief executive, and Ashar Mahboob is its chief investment officer.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
CVS Health
CVS
|
+$9.6M |
| 2 |
Teva Pharmaceutical Industries Limited
TEVA
|
+$8.95M |
| 3 |
Sherwin-Williams
SHW
|
+$8.84M |
| 4 |
AB InBev
BUD
|
+$7.79M |
| 5 |
Apple
AAPL
|
+$7.76M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Automatic Data Processing
ADP
|
+$12.4M |
| 2 |
Lowe's Companies
LOW
|
+$9.7M |
| 3 |
Cardinal Health
CAH
|
+$9.29M |
| 4 |
McKesson
MCK
|
+$8.56M |
| 5 |
Coca-Cola
KO
|
+$7.7M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 16.34% |
| 2 | Consumer Discretionary | 14.86% |
| 3 | Industrials | 13.03% |
| 4 | Financials | 11.85% |
| 5 | Technology | 10.67% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
1001
DELISTED
Seadrill Limited Common Stock
SDRL
| $27K | ﹤0.01% |
+17
| New | +$36.3K |
2015 Q3
0 quarters
|
|
1002
Canadian National Railway
CNI
$76.1B
| $26K | ﹤0.01% |
+469
| New | +$27.3K |
2015 Q3
0 quarters
|
|
1003
Ryanair
RYAAY
$31.8B
| $26K | ﹤0.01% |
+838
| New | +$25.9K |
2015 Q3
0 quarters
|
|
1004
Zumiez
ZUMZ
$222M
| $26K | ﹤0.01% |
+1,720
| New | +$39.2K |
2015 Q3
0 quarters
|
|
1005
Trustmark
TRMK
$2.62B
| $25K | ﹤0.01% |
1,113
-11,126
| -91% | -$264K |
2015 Q2
1 quarter
|
|
1006
Tronox
TROX
$460M
| $25K | ﹤0.01% |
5,860
-2,875
| -33% | -$26.7K |
2013 Q4
7 quarters
|
|
1007
Korn Ferry
KFY
$4.23B
| $24K | ﹤0.01% |
733
-339
| -32% | -$11.6K |
2015 Q2
1 quarter
|
|
1008
DELISTED
Intra-Cellular Therapies Inc.
ITCI
| $24K | ﹤0.01% |
+616
| New | +$20.1K |
2015 Q3
0 quarters
|
|
1009
Kulicke & Soffa
KLIC
$3.61B
| $23K | ﹤0.01% |
2,600
-14,063
| -84% | -$145K |
2015 Q2
1 quarter
|
|
1010
Kestrel Group
KG
$34.9M
| $23K | ﹤0.01% |
+86
| New | +$26.4K |
2015 Q3
0 quarters
|
|
1011
DELISTED
SANGAMO THERAPEUTICS INC
SGMO
| $23K | ﹤0.01% |
4,200
+3,800
| +950% | +$31.3K |
2014 Q4
3 quarters
|
|
|
STKL
1012
DELISTED
SunOpta
STKL
| $23K | ﹤0.01% |
+4,929
| New | +$44.7K |
2015 Q3
0 quarters
|
|
1013
Vanda Pharmaceuticals
VNDA
$252M
| $23K | ﹤0.01% |
2,100
-10,613
| -83% | -$130K |
2015 Q2
1 quarter
|
|
|
BBEP
1014
DELISTED
BREITBURN ENERGY PARTNERS LP COM UNITS RPTNG LTD PRTNRSHIP
BBEP
| $23K | ﹤0.01% |
11,573
-7,158
| -38% | -$21.3K |
2014 Q4
3 quarters
|
|
1015
Crane NXT
CXT
$3.32B
| $22K | ﹤0.01% |
1,379
-15,860
| -92% | -$292K |
2015 Q1
2 quarters
|
|
|
PETX
1016
DELISTED
Aratana Therapeutics, Inc.
PETX
| $22K | ﹤0.01% |
+2,669
| New | +$45.2K |
2015 Q3
0 quarters
|
|
1017
Ashford Hospitality Trust
AHT
$14.6M
| $21K | ﹤0.01% |
+3
| New | +$23.9K |
2015 Q3
0 quarters
|
|
1018
Constellium
CSTM
$3.01B
| $21K | ﹤0.01% |
+3,533
| New | +$29.4K |
2015 Q3
0 quarters
|
|
1019
Quest Diagnostics
DGX
$28.5B
| $21K | ﹤0.01% |
+342
| New | +$23.9K |
2015 Q3
0 quarters
|
|
1020
Fabrinet
FN
$12.1B
| $21K | ﹤0.01% |
+1,200
| New | +$22.6K |
2015 Q3
0 quarters
|
|
|
QIWI
1021
DELISTED
QIWI PLC
QIWI
| $21K | ﹤0.01% |
+1,321
| New | +$32.3K |
2015 Q3
0 quarters
|
|
|
NWBO
1022
DELISTED
Northwest Biotherapeutics, Inc. Common stock
NWBO
| $21K | ﹤0.01% |
3,488
+2,688
| +336% | +$25.1K |
2015 Q2
1 quarter
|
|
1023
Celldex Therapeutics
CLDX
$2.42B
| $20K | ﹤0.01% |
+127
| New | +$35.9K |
2015 Q3
0 quarters
|
|
1024
CONMED
CNMD
$1.53B
| $20K | ﹤0.01% |
+427
| New | +$23.4K |
2015 Q3
0 quarters
|
|
1025
FirstCash
FCFS
$7.84B
| $20K | ﹤0.01% |
510
-175
| -26% | -$7.17K |
2015 Q2
1 quarter
|
|
Similar funds
Quantbot Technologies's Q3 2015 Portfolio in Review
As of Q3 2015, Quantbot Technologies held 1,663 positions worth $574M, up 2.8% from $558M the previous quarter. Its ten largest holdings account for 14% of the portfolio.
Quantbot Technologies deployed $92.1M of net new capital in Q3 2015, opening 580 new positions and adding to 342 existing holdings. Its largest new stake was CVS Health: 91,570 shares worth $8.83M.
By sector, the portfolio is most concentrated in Healthcare at 16% of assets, up from 12% a quarter earlier, followed by Consumer Discretionary and Industrials.
On the sell side, the largest reduction was Cardinal Health, an estimated $9.29M trimmed.
- Quantbot Technologies's largest Q3 2015 buy was CVS Health: 91,570 shares worth $8.83M.
- Quantbot Technologies added most to Sherwin-Williams in Q3 2015, an estimated $8.84M increase.
- Quantbot Technologies's biggest Q3 2015 reduction was Cardinal Health, cutting an estimated $9.29M.
- Quantbot Technologies fully exited Automatic Data Processing in Q3 2015, selling an estimated $12.4M.
- Quantbot Technologies's ten largest holdings make up 14% of its $574M portfolio in Q3 2015.
- Quantbot Technologies opened 580 new positions and closed 499 in Q3 2015.
- Quantbot Technologies's portfolio value rose 2.8% quarter-over-quarter to $574M.
Based on Quantbot Technologies's 13F filing for Q3 2015, filed 22 Oct 2015.